{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,24]],"date-time":"2023-10-24T22:56:17Z","timestamp":1698188177631},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2007,1,9]],"date-time":"2007-01-09T00:00:00Z","timestamp":1168300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2007,7,26]]},"DOI":"10.1007\/s00192-006-0271-y","type":"journal-article","created":{"date-parts":[[2007,1,8]],"date-time":"2007-01-08T04:24:14Z","timestamp":1168230254000},"page":"1021-1025","source":"Crossref","is-referenced-by-count":7,"title":["Comparison of the efficacy and tolerability of solifenacin succinate with or without previous use of trospium chloride"],"prefix":"10.1007","volume":"18","author":[{"given":"J.","family":"Metello","sequence":"first","affiliation":[]},{"given":"B.","family":"Nogueira","sequence":"additional","affiliation":[]},{"given":"M.","family":"Torgal","sequence":"additional","affiliation":[]},{"given":"J.","family":"Cola\u00e7o","sequence":"additional","affiliation":[]},{"given":"A.","family":"Vieira","sequence":"additional","affiliation":[]},{"given":"V.","family":"Gon\u00e7alves","sequence":"additional","affiliation":[]},{"given":"H.","family":"Retto","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,1,9]]},"reference":[{"key":"271_CR1","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1046\/j.1464-410x.2001.02228.x","volume":"87","author":"I Milsom","year":"2001","unstructured":"Milsom I, Abrams P, Cardozo L et al (2001) How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study. BJU Int 87:760\u2013766","journal-title":"BJU Int"},{"key":"271_CR2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","volume":"21","author":"P Abrams","year":"2002","unstructured":"Abrams P, Cardozo L, Fall M et al (2002) The standardization of terminology of lower urinary tract function: report from the Standardization Sub-committee of the International Continence Society. Neurourol Urodyn 21:167\u2013178","journal-title":"Neurourol Urodyn"},{"key":"271_CR3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","volume":"7","author":"KS Coyne","year":"2004","unstructured":"Coyne KS, Payne C, Bhattacharyya SK et al (2004) The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey. Value Health 7:455\u2013463","journal-title":"Value Health"},{"key":"271_CR4","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1517\/14656566.6.8.1409","volume":"6","author":"NR Zinner","year":"2005","unstructured":"Zinner NR (2005) Trospium chloride: an anticholinergic quaternary ammonium compound for the treatment of overactive bladder. Expert Opin Pharmacother 6:1409\u20131420","journal-title":"Expert Opin Pharmacother"},{"key":"271_CR5","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2165\/00003495-200464210-00005","volume":"64","author":"ES Rovner","year":"2004","unstructured":"Rovner ES (2004) Trospium chloride in the management of overactive bladder. Drugs 64:2433\u20132446","journal-title":"Drugs"},{"key":"271_CR6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.clinthera.2005.05.008","volume":"27","author":"D Singh-Franco","year":"2005","unstructured":"Singh-Franco D, Machado C, Tuteja S, Zapantis A (2005) Trospium chloride for the treatment of overactive bladder with urge incontinence. Clin Ther 27:511\u2013530","journal-title":"Clin Ther"},{"key":"271_CR7","first-page":"489","volume-title":"Incontinence. Second International Consultation on Incontinence","author":"KE Andersson","year":"2002","unstructured":"Andersson KE et al (2002) Pharmacological treatment of urinary incontinence. In: Abrams P, Khoury S, Wein A (eds) Incontinence. Second International Consultation on Incontinence. Plymbridge Distributors, Plymouth, United Kingdom, pp 489\u2013511"},{"key":"271_CR8","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/S0022-5347(05)66326-4","volume":"165","author":"J Malone-Lee","year":"2001","unstructured":"Malone-Lee J, Shaffu B, Anand C, Powell C (2001) Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50\u00a0years old or older with overactive bladder: a randomized controlled trial. J Urol 165:1452\u20131456","journal-title":"J Urol"},{"key":"271_CR9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00002512-200118070-00007","volume":"18","author":"P Abrams","year":"2002","unstructured":"Abrams P, Malone-Lee J, Jacquetin B et al (2002) Twelve-month treatment of overactive bladder: efficacy and tolerability of tolterodine. Drugs Aging 18:551\u2013560","journal-title":"Drugs Aging"},{"key":"271_CR10","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1097\/01.ju.0000140729.07840.16","volume":"172","author":"L Cardozo","year":"2004","unstructured":"Cardozo L, Lisec M, Millard R et al (2004) Randomized, double-blind placebo controlled trial of the once daily antimuscarinic agent solifenacin succinate in patients with overactive bladder. J Urol 172:1919\u20131924","journal-title":"J Urol"},{"key":"271_CR11","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1464-410X.2004.04606.x","volume":"93","author":"CR Chapple","year":"2004","unstructured":"Chapple CR, Rechberger T, Al-Shukri S et al (2004) Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder. BJU Int 93:303\u2013310","journal-title":"BJU Int"},{"key":"271_CR12","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2005.05.015","volume":"48","author":"CR Chapple","year":"2005","unstructured":"Chapple CR, Martinez-Garcia R, Selvaggi L et al (2005) A comparison of the efficacy and tolerability of solifenacin succinate and extended release tolterodine at treating overactive bladder syndrome: results of the STAR trial. Eur Urol 48:464\u2013470","journal-title":"Eur Urol"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-006-0271-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00192-006-0271-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-006-0271-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T14:56:29Z","timestamp":1558623389000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00192-006-0271-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2007,7,26]]}},"alternative-id":["271"],"URL":"https:\/\/doi.org\/10.1007\/s00192-006-0271-y","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,9]]}}}